InforSense Signs Dana-Farber as Latest Partner for Translational Research Platform | GenomeWeb
InforSense this week said that it has entered into a three-year collaboration with Dana-Farber Cancer Institute to develop a translational research informatics infrastructure that will give researchers at the institute ready access to clinical and experimental data.
 
The agreement marks InforSense’s third translational research deal with a major cancer research organization and helps secure its presence in a field where there is growing demand for informatics solutions, but no off-the-shelf commercial products.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.